261 related articles for article (PubMed ID: 17973312)
1. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
[TBL] [Abstract][Full Text] [Related]
2. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
[TBL] [Abstract][Full Text] [Related]
3. Expression of liquoral neuroprotection markers in children with acute lymphoblastic leukemia.
Chiaretti A; Ruggiero A; Coccia P; Antonelli A; Pierri F; Barone G; Attinà G; Iuvone L; Maurizi P; Riccardi R
Leuk Res; 2011 Nov; 35(11):1467-71. PubMed ID: 21846577
[TBL] [Abstract][Full Text] [Related]
4. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
Trysberg E; Nylen K; Rosengren LE; Tarkowski A
Arthritis Rheum; 2003 Oct; 48(10):2881-7. PubMed ID: 14558094
[TBL] [Abstract][Full Text] [Related]
5. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
[TBL] [Abstract][Full Text] [Related]
6. Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia.
Miketova P; Kaemingk K; Hockenberry M; Pasvogel A; Hutter J; Krull K; Moore IM
Biol Res Nurs; 2005 Jan; 6(3):187-95. PubMed ID: 15583359
[TBL] [Abstract][Full Text] [Related]
7. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
[TBL] [Abstract][Full Text] [Related]
8. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
9. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
Vlacha V; Eliopoulou M; Haidas S; Beratis NG
Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
[TBL] [Abstract][Full Text] [Related]
10. Effect of chemotherapy on ascorbate and ascorbyl radical in cerebrospinal fluid and serum of acute lymphoblastic leukemia.
Nakagawa K
Cell Mol Biol (Noisy-le-grand); 2000 Dec; 46(8):1375-81. PubMed ID: 11156482
[TBL] [Abstract][Full Text] [Related]
11. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
[TBL] [Abstract][Full Text] [Related]
12. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical aftermath of amateur boxing.
Zetterberg H; Hietala MA; Jonsson M; Andreasen N; Styrud E; Karlsson I; Edman A; Popa C; Rasulzada A; Wahlund LO; Mehta PD; Rosengren L; Blennow K; Wallin A
Arch Neurol; 2006 Sep; 63(9):1277-80. PubMed ID: 16966505
[TBL] [Abstract][Full Text] [Related]
14. Neurological injury markers in children with septic shock.
Hsu AA; Fenton K; Weinstein S; Carpenter J; Dalton H; Bell MJ
Pediatr Crit Care Med; 2008 May; 9(3):245-51. PubMed ID: 18446104
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis.
Gavhed D; Akefeldt SO; Osterlundh G; Laurencikas E; Hjorth L; Blennow K; Rosengren L; Henter JI
Pediatr Blood Cancer; 2009 Dec; 53(7):1264-70. PubMed ID: 19688833
[TBL] [Abstract][Full Text] [Related]
16. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-associated alterations of the folate and methyl-transfer pathway in the CSF of ALL patients with and without symptoms of neurotoxicity.
Vezmar S; Schüsseler P; Becker A; Bode U; Jaehde U
Pediatr Blood Cancer; 2009 Jan; 52(1):26-32. PubMed ID: 19006245
[TBL] [Abstract][Full Text] [Related]
18. Changes in cell and protein content of cerebrospinal fluid in children with acute lymphoblastic leukaemia after allogeneic bone marrow transplantation.
van den Berg H; Gerritsen EJ; Haraldsson A; Vossen JM
Bone Marrow Transplant; 1993 Dec; 12(6):615-9. PubMed ID: 8136745
[TBL] [Abstract][Full Text] [Related]
19. [Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia].
Xu WQ; Tang YM; Fang CQ; Song H; Shi SW; Yang SL; Ren DT; Shen HQ; Qian BQ
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):15-8. PubMed ID: 15946502
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
